Clinical trial
Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed…
NCT00497523 · Chiesi Farmaceutici S.p.A., Industry · Completed
Key facts
| NCT number | NCT00497523 |
|---|---|
| Title | Efficacy and Safety of Nebulised Beclomethasone Dipropionate Plus as Needed Salbutamol vs as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination in Young Children With Asthma Symptoms |
| Official title | Double Blind, Multinational, Multicentre, Parallel-group, Placebo-controlled Design Trial of the Efficacy and Safety of Nebulised Beclometahsone Dipropionate (400 μg b.i.d.) Plus as Needed Salbutamol Versus as Needed Salbutamol or as Needed Salbutamol/Beclomethasone Fixed Combination, in the 12-week… |
| Lead sponsor | Chiesi Farmaceutici S.p.A., Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Bronchial Asthma |
| Intervention type | Drug |
| Interventions | Beclomethasone dipropionate, Beclomethasone dipropionate/Salbutamol combination, Salbutamol |
| Enrollment | 283 |
| Start date | Mar 1, 2006 |
| Completion | Jan 1, 2007 |
| First posted | Jul 6, 2007 |
| Last update posted | Aug 3, 2020 |
| Countries | Poland, Ukraine |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: